SPRY - ARS Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

SPRY is currently covered by 4 analysts with an average price target of $23. This is a potential upside of $20.04 (677.03%) from yesterday's end of day stock price of $2.96.

ARS Pharmaceuticals's activity chart (see below) currently has 39 price targets and 37 ratings on display. The stock rating distribution of SPRY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 19.94% of the time, taking 285.38 days on average.

Highest price target for SPRY is $30, Lowest price target is $17, average price target is $23.

Most recent stock forecast was given by JOSHUA SCHIMMER from CANTOR FITZGERALD on 05-Nov-2026. First documented stock forecast 12-Dec-2022.

Best performing analysts who are covering SPRY - ARS Pharmaceuticals:

Andreas Argyrides Roanna Ruiz Joshua Schimmer Louise Chen Ryan Deschner Jason Wittes

Currently out of the existing stock ratings of SPRY, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Sep-2024

$20

$17.04 (575.68%)

$30

15 days ago
(05-Nov-2026)

0/7 (0%)

$17.21 (616.85%)

Buy Since 24-Jul-2024

$17

$14.04 (474.32%)

15 days ago
(05-Nov-2026)

1/11 (9.09%)

$14.21 (509.32%)

336

Buy Since 20-Sep-2024

$24

$15.46 (181.03%)

$27

4 months 27 days ago
(25-Jun-2026)

1/4 (25%)

$15.98 (199.25%)

615

Buy Since 06-Mar-2025

$30

$27.04 (913.51%)

$30

6 months 6 days ago
(14-May-2026)

0/2 (0%)

$22.57 (303.77%)

Buy Since 03-Sep-2025

$30

$40

1 years 17 days ago
(03-Nov-2025)

0/2 (0%)

$21.29 (244.43%)

Show more analysts

Please expand the browser size to see the chart

What is SPRY (ARS Pharmaceuticals) average time for price targets to be met?

On average it took 285 days for the stock forecasts to be reached, with an average price target met ratio of 19.94%.

Which analyst most recently updated their price target on SPRY (ARS Pharmaceuticals)?

Josh Schimmer

Which analyst has the lowest performance score on SPRY (ARS Pharmaceuticals) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on SPRY (ARS Pharmaceuticals)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 3 ratings on SPRY

Which analyst is the currently most bullish on SPRY (ARS Pharmaceuticals)?

Louise Chen with the highest potential upside of $27.04

Which analyst is the currently most reserved on SPRY (ARS Pharmaceuticals)?

Ryan Deschner with the lowest potential downside of $14.04
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?